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VEGF-A signaling is required for almost every aspect of vascular development, and it is a
major regulator of vessel morphogenesis and patterning. VEGF-A perturbations are associ-
ated with severe vascular defects and lethality, and the pathway is coopted in pathological
scenarios, including tumor angiogenesis. This review focuses on the roles of VEGF-A signal-
ing during vessel development and patterning. I review the impact of VEGF-A signaling on
endothelial cells in developing vessels, with emphasis on the importance of spatial regu-
lation of several pathway components. I also discuss VEGF-A signaling patterns at the
level of the vessel, with a focus on how polarity is set up and maintained in several vessel
axes. The role of VEGF-A in patterning vessels relative to tissues and organs is also reviewed,
with emphasis on neurovascular patterning and patterning at the embryonic midline.
VEGF-A (vascular endothelial growth factor,VEGF) is important for almost every as-
pect of blood vessel formation and function.
VEGF-A is required developmentally for the
differentiation and/or expansion of angio-
blasts, the major precursor of endothelial cells.
It is critical for the survival of endothelial cells,
and the angiogenic expansion of primitive ves-
sels via sprouting requires VEGF-A signaling.
It also regulates barrier function in mature ves-
sels. Other members of the VEGF family have
roles in lymphangiogenesis and/or in patholog-
ical angiogenesis. My goal is to focus on the role
of VEGF-A (VEGF) in blood vessel patterning
and network formation. Thus, I will briefly out-
line the VEGF proteins and receptors that are
relevant to vessel patterning, then discuss how
VEGF patterns vessels at three levels—that of
the cell, the vessel, and the tissue/organism.
The cellular effects of VEGF on vessel develop-
ment cover spatial heterogeneity in VEGF pre-
sentation and signaling, the role of the VEGF
receptor Flt-1, and the role of VEGF isoforms
and matrix in this process. The mechanisms
used by the VEGF pathway are compared and
contrasted with other pathways that regulate
morphogenesis in other developing models.
At the level of the vessel, the polarity of vascular
endothelial cells that is required for lumen for-
mation, the polarization to shear stress, and
the polarization of endothelial divisions to
affect vessel shape are discussed. Next, how
VEGF signaling is used to set up patterning at
the level of tissues and organisms is covered,
with a focus on midline and neural tube pat-
terning. Finally, I discuss some outstanding
Editors: Michael Klagsbrun and Patricia D’Amore
Additional Perspectives on Angiogenesis available at www.perspectivesinmedicine.org
Copyright # 2012 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a006452




















questions related to VEGF-induced vessel pat-
terning and highlight how current research
will lead to a better understanding of how
VEGF signaling is regulated, and why this regu-
lation is important therapeutically.
GENERAL DESCRIPTION OF VEGF EFFECTS
ON VESSELS
VEGF signaling is critical to the expansion of
angioblasts that coalesce to form the initial ves-
sels, such as the dorsal aorta, via vasculogenesis
(for reviews, see Risau 1997; Cleaver and Krieg
1999; Coultas et al. 2005). It is also required
for subsequent endothelial cell sprouting
migration that leads to the expansion and pat-
terning of the vessel network via angiogenesis.
The primary ligand in vessel expansion and pat-
terning is VEGF-A (referred to as VEGF in this
review), and genetic deletion of even one copy
of VEGF-A is embryonic-lethal because of lack
of vessel development, suggesting that VEGF
regulates vascular processes within a relatively
narrow range of ligand concentration (Carme-
liet et al. 1996; Ferrara et al. 1996). This quanti-
tative regulation is accompanied by spatial
regulation of VEGF-A presentation to nascent
vessels via alternative splicing of VEGF-A to
yield three major isoforms with different affin-
ities for the extracellular matrix (Park et al.
1993).
VEGF-A interacts with two high-affinity re-
ceptors, VEGFR-2 (Flk-1, KDR) and VEGFR-1
(Flt-1). VEGF binding to VEGFR-2/Flk-1 stim-
ulates endothelial cell proliferation, migration,
and survival; and genetic loss of flk-1 in mice
leads to embryonic lethality with loss of vessel
development (Shalaby et al. 1995). Genetic
loss of flt-1 also leads to embryonic lethality,
but with vessel overgrowth and dysmorphogen-
esis (Fong et al. 1995). This phenotype results
from increased endothelial cell proliferation
and elevated signaling through VEGFR-2, sug-
gesting that VEGFR-1 acts to negatively modu-
late VEGF signaling during development
(Kearney et al. 2002; Roberts et al. 2004). Neu-
ropilin coreceptors interact with the VEGF
receptors to positively modulate signaling
(Soker et al. 1998; Whitaker et al. 2001), and
genetic loss of Neuropilin-1 results in vascular
migration defects, with poorly branched and
dilated vessels leading to lethality (Kawasaki
et al. 1999; Gu et al. 2003).
EFFECTS OF VEGF ON ENDOTHELIAL CELLS
IN DEVELOPING VESSELS
Evidence that VEGF signaling is spatially regu-
lated came from the identification of alterna-
tively spliced isoforms as described in the
previous section—the major VEGF isoforms
(Fig. 1A) result from splicing that removes one
or two exons with heparin-binding matrix-
interaction domains, such that VEGF121 is pre-
dicted to be more diffusible, VEGF165 less dif-
fusible, and VEGF189 to have the strongest
matrix interactions and be the least diffusible
(for review, see Ferrara 2010). This suggests
that expression of all three isoforms from a tis-
sue expressing VEGF sets up a gradient, with the
highest concentration of ligand closest to the
source (Fig. 2). Physical evidence for gradients
in vivo is difficult to obtain, but antibody stain-
ing suggests such a VEGF gradient in the de-
veloping hindbrain (Ruhrberg et al. 2002).
Moreover, expression of only the VEGF120 iso-
form (mouse VEGF isoforms have one less
amino acid than the human versions) in devel-
oping mouse embryos leads to dilated and
poorly branched vessels along with lethality,
whereas expression of only the heparin-binding
VEGF188 isoform leads to thin and overly
branched vessels (Ruhrberg et al. 2002; Stal-
mans et al. 2002). These genetic data strongly
indicate that regulated spatial VEGF presenta-
tion is important for proper vessel morphogen-
esis. One model that explains these results is that
a proper VEGF gradient is necessary to stimu-
late sprouting and branching, whereas overall
VEGF levels regulate endothelial proliferation.
The relative amount of proliferation versus
sprouting is important for network formation,
and loss of this integration leads to proliferation
in the absence of sprouting (VEGF120/120
mice) or excessive sprouting relative to prolifer-
ation (VEGF188/188 mice) and aberrant mor-
phogenesis. This model is reinforced by the
finding that tumor expression of a VEGF-A
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protein that cannot be proteolytically cleaved
and released from the matrix results in thin,
highly branched vessels, whereas similar ex-
pression of a cleaved version of VEGF-A leads
to dilated tumor vessels (Lee et al. 2005).
Recent data also indicate that matrix-bound
VEGF stimulates sustained signaling through
VEGFR-2 and activation of downstream path-
ways distinct from those activated by soluble
VEGF, suggesting how proliferation and
branching might be integrated via a VEGF gra-
dient (Chen et al. 2010). Finally, endothelial
cells themselves express low levels of VEGF
that contribute to vessel homeostasis, and per-
haps also to sprouting migration via integrin
regulation of VEGFR-2 (Lee et al. 2007; da Silva
et al. 2010). Taken together, these data highlight
that VEGF-A presentation is important for
proper vessel morphogenesis and is controlled
by several mechanisms that spatially regulate
ligand availability.
Several years ago, the concept of “tip” cell
and “stalk” cell phenotypes was described for
emerging sprouts (Gerhardt et al. 2003). Briefly,
the tip cell is the leading cell of a sprout that
presumably experiences higher levels of VEGF
signaling, whereas the cells behind the tip cell
are stalk cells that likely experience lower levels
of VEGF signaling, and this difference is main-
tained by interactions of the VEGF pathway
with the Notch–Delta pathway (Hellstrom
et al. 2007; Lobov et al. 2007; Suchting et al.
2007; Siekmann et al. 2008). It is essential that
forming vessel networks have a distribution of
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Figure 1. Alternative splicing of VEGF-A and VEGFR-1 (Flt-1) leads to distinct isoforms. (A) Alternative
splicing of the initial transcript from the VEGF-A locus leads to three major VEGF-A isoforms (minor isoforms
not shown): VEGF121, VEGF165, and VEGF189 (in mouse, VEGF120, VEGF164, and VEGF188). Exons 6
and 7 have heparin-binding domains, thus each major isoform has a different capacity for matrix inter-
actions. (B) Alternative splicing of VEGFR-1 (Flt-1) leads to the two protein isoforms shown here. mFlt-1 is
membrane-tethered, whereas sFlt-1 is secreted from the cell. Both Flt-1 isoforms have heparin-binding capabil-
ity. Blue sections are shared by both isoforms, the red section is specific to sFlt-1, and purple sections are spe-
cific to mFlt-1.
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tip and stalk cells—too many tip cells leads to
poor vessel perfusion, whereas too many stalk
cells results in poorly arborized networks. Other
articles in this collection discuss this paradigm
more comprehensively; however, it is important
to note that spatial differences in VEGF signal-
ing are critical to these phenotypic changes—
endothelial cells that experience higher levels
of VEGF signaling are preferentially found at
the tip position in competition experiments
(Jakobsson et al. 2010).
The VEGF receptor Flt-1 (VEGFR-1) is al-
ternatively spliced to produce soluble (sFlt-1)
and membrane-localized (mFlt-1) isoforms
(Fig. 1B) (Kendall and Thomas 1993), and the
differential effects of these isoforms on vessel
patterning suggest that VEGF signaling is spa-
tially regulated by localized Flt-1 expression
(Kappas et al. 2008; Chappell et al. 2009).
Both Flt-1 isoforms bind VEGF-A with higher
affinity than does Flk-1 (Park et al. 1994), and
they can function as competitive inhibitors of
the pathway via ligand binding. Negative mod-
ulation of VEGF signaling is likely the predom-
inant mechanism whereby Flt-1 regulates
developmental angiogenesis, because mice lack-
ing the Flt-1 cytoplasmic domain required for
signaling are viable (Hiratsuka et al. 1998).
Genetic rescue of flt-1 mutant vessels with
mFlt-1 rescues only proliferation defects,
whereas rescue with sFlt-1 rescues both prolifer-
ation and branching defects, indicating that the
Flt-1 isoforms differentially affect vessel prolif-
eration versus sprouting (Kappas et al. 2008).
Because sFlt-1 is secreted from endothelial cells,
this moiety can bind and potentially inactivate
VEGF at a distance from the producing cell.
Flt-1 has heparin-binding properties (Park
Figure 2. Model of spatial organization of VEGF-A signaling components. VEGF-A is released from a source (top
of figure) and, owing to isoform-specific differences in matrix interactions, forms a gradient (green areas) from
the source to the target vessel. Some endothelial cells respond to this signal by acquiring a tip cell (red cell) iden-
tity and migrating up the gradient, whereas adjacent lateral base cells (orange cells) up-regulate Flt-1 (VEGFR-1)
and secrete soluble Flt-1 (blue areas) that inactivates VEGF-A in the lateral areas, providing a corridor of ligand
for effective outward migration of the sprout. (Green icons) VEGF-A protein; (blue receptors) membrane-
localized and soluble Flt-1.
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and Lee 1999), suggesting that it can form a gra-
dient into the matrix from its source, the devel-
oping vessel. We recently proposed a model
whereby initial stochastic differences in sFlt-1
production by individual endothelial cells of a
developing vessel result in increased expression
of sFlt-1 by cells adjacent to an emerging sprout,
and this expression is proposed to provide
localized VEGF inactivation and thus more
active ligand in the area immediately ahead of
the migrating sprout (Fig. 2) (Chappell et al.
2009). Evidence for this model of Flt-1-depend-
ent local sprout guidance is that vessels lacking
flt-1 have misguided sprouts, and mosaic anal-
ysis reveals a requirement for sFlt-1 in endothe-
lial cells immediately adjacent to the sprout for
proper sprout guidance.
There are several parallels between VEGF
signaling and other pathways that influence
developmental morphogenesis. Numerous sig-
naling pathways important in development are
thought to act via gradients, including Wnt,
Dpp, and Shh (for review, see Ashe and Briscoe
2006). These gradients are regulated in complex
ways. For example, the Wnt receptor Frizzled
also has soluble forms, although they are
produced by distinct genetic loci (Bovolenta
et al. 2008). Soluble Frizzled-related proteins
(sFRP) are proposed to influence Wnt signaling
in several ways, including acting as antagonists
or paradoxically acting to diffuse the Wnt
ligand (Mii and Taira 2009). There are also
other negative regulators of Wnt/Wg signaling
that are instigated by the signaling cascade
and modify the interpretation of the gradient.
One example is notum (also called wingful), a
gene encoding a secreted phospholipase that
potently inhibits Wg signaling that is expressed
in cells adjacent to Wg-producing cells at the
D-V midline (Piddini and Vincent 2009). Like-
wise, a complex regulatory loop that includes
both positive and negative regulators induced
by Shh signaling modifies the initial Shh signal
that patterns the vertebrate neural tube in
the D-V axis (for review, see Ribes and Briscoe
2009). Finally, similar to the VEGF ligand,
numerous secreted morphogens (i.e., Wnt,
Hh, and BMP) interact with heparan sulfate
proteoglycans to control morphogen move-
ment and signaling (for review, see Yan and
Lin 2009).
HOW VEGF PATTERNS NASCENT BLOOD
VESSELS
VEGF signaling is also important develop-
mentally for the coordinated responses of
endothelial cells that result in polarized and
lumenized vessels (for reviews, see Iruela-
Arispe and Davis 2009; Ellertsdottir et al.
2010; Zeeb et al. 2010). Endothelial cells in
vessels polarize in several planes (Fig. 3). Early
in development, endothelial cells distinguish







Figure 3. Blood vessel polarity. Blood vessels polarize in the apical (luminal) versus basolateral (abluminal)
planes, and in the plane of the tube (planar cell polarity). (Right panel) The mouse P5 retinal vessel stained
with isolectin B4 (red) after perfusion fixation with the same lectin (labeled in green). Arrows point to mem-
branes that have both labels and are likely to be the apical surfaces, and the inset in the upper right shows a Z-stack
projection.
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endothelial cells (luminal or apical) from the
surface that faces outward toward the extracellu-
lar matrix/basement membrane (abluminal or
basolateral) (Fig. 3). The luminal side is the
eventual site of lumen formation, and new
lumens connect to more mature lumens with
blood flow. Endothelial cells subsequently ori-
ent in the plane of the vessel (planar cell polar-
ity) in response to shear stress provided by
blood flow, at least in large conduit vessels
(for review, see McCue et al. 2004). Finally,
they also orient their spindles as they divide,
and in developing vessel networks this orienta-
tion puts the cleavage plane perpendicular to
the vessel long axis and extends the length of
the vessel (Zeng et al. 2007).
The first polarization of a nascent vessel is
the apical/basolateral polarization that is re-
quired for regulated endothelial transcytosis
and lumen formation. It has been relatively dif-
ficult to localize polarity complexes that are pre-
dicted to be apical or basolateral in endothelial
cells, in part, because normal endothelial cell
shape places the apical surface close to the
basolateral surface, and there is little depth to
the lateral surface. A recent study investigated
the forming dorsal aorta in early mouse
embryos (Strilic et al. 2009). They found that
apical markers localize to the inner surfaces of
the endothelial cells before lumen formation,
and loss of junctions or acto-myosin contractil-
ity perturbed this process. They provided evi-
dence that lumen formation involves apical
polarization of sialomucins that prevent junc-
tional contact, and that subsequent cell shape
changes produce the lumen. Interestingly,
genetic loss of Vegfa resulted in lack of
lumen formation. Cell-based data suggested
that VEGF signaling is upstream of Rho kinase
and non-muscle myosin-induced cell shape
changes, but polarization per se was not affected
by loss of Vegfa. This model of lumenization is
consistent with the concept that apical–baso-
lateral polarization is a prerequisite for lumen
formation, perhaps because of a requirement
for polarized trafficking of specific molecules
and/or vesicles, and that VEGF-influenced
events subsequent to polarization are also
important. In other vessel beds, there is
polarized trafficking of vesicles or vacuoles to
specific cell surfaces and/or the middle of cells
to instigate lumen formation (Kamei et al.
2006; Blum et al. 2008).
The basolateral side of the endothelial cell
provides information for polarization to devel-
oping vessels. Basolateral areas interact with
extracellular matrix, and integrin signaling via
binding sites in the ECM contributes to the
establishment of polarity. Genetic deletion of
b1 integrin has been particularly informative,
perhaps because several endothelial integrin
heterodimers (i.e., a1, a2 a3, a4, a5, a6, av
heterodimers with b1) are affected by loss of
b1 integrin. Several studies showed that b1
loss in endothelial cells results in aberrant endo-
thelial adhesion and migration, and consequent
defects in angiogenesis and embryonic lethality
(Tanjore et al. 2007; Carlson et al. 2008). Zovein
et al. (2010) specifically investigated effects of
endothelial b1 loss on apical–basolateral polar-
ity and reported that arteries are selectively
affected. Endothelial cells lacking b1 integrin
did not form proper basolateral connections,
but entered and occluded the lumen. The
polarity protein Par3 appears to be an effector
of the phenotype, because Par3 levels were
reduced with loss of b1, and Par3 expression
partially rescued the lumen phenotype (Zovein
et al. 2010).
Once basolateral polarity is set up and
lumens form and interconnect, blood flow
commences, and the endothelial cells of conduit
vessels orient in the plane set up by the long axis
of the cells, which is called planar cell polarity.
This orientation is seen in culture when
cells are subjected to shear stress produced by
flow, and it results in the orientation of the
microtubule-organizing center (MTOC) and
the Golgi downstream from the flow vector.
This flow orientation requires transduction
of mechanical cues, and it is thought that
several complexes contribute to flow-mediated
mechanotransduction (for review, see Hahn
and Schwartz 2009). Among these are a complex
that includes the VEGF receptor VEGFR-2
(Flk-1), PECAM-1, and VE-cadherin, although
VEGF itself does not appear to be involved in
the signaling (Tzima et al. 2005).
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Although most of the effects of shear stress
on endothelial cells have been deduced from
in vitro models, this polarization is clearly med-
ically relevant in vivo because areas of disturbed
flow are the sites of inflammatory signaling and
atherosclerotic plaque development. Endothe-
lial cells in vessel areas exposed to laminar
flow orient their MTOC relative to the nucleus
and the flow vector, although the actual orienta-
tion of the MTOC relative to flow is not always
downstream but varies depending on the
vascular bed. Endothelial cells also orient cell
divisions with the cleavage plane perpendicular
to the direction of flow in high-flow vessels such
as the carotid artery (McCue et al. 2006). How-
ever, oriented endothelial divisions appear to
be flow independent and VEGF dependent at
early developmental stages. Embryonic stem
cell–derived vessels that do not experience
flow orient endothelial cell divisions with the
cleavage plane perpendicular to the vessel long
axis, and retinal vessels near the vascular front
that likely have low shear stress also orient
endothelial divisions, perhaps in order to
extend vessel length in expanding vascular net-
works (Zeng et al. 2007). Elevated VEGF signal-
ing due to loss of the negative modulator
VEGFR-1 (Flt-1) results in randomization of
endothelial division orientation, although
expression of only the VEGF120 isoform does
not significantly randomize endothelial divi-
sion orientation in developing retinas (Zeng
et al. 2007; SM Taylor, H Park, G Zeng, et al.,
unpubl.).
Finally, as vessels form and expand, mural
cells are found associated with the basolateral
side of endothelial cells. Virtually all vessels
are invested with pericytes, and larger vessels
also become covered with smooth muscle cells,
and sometimes with fibroblasts (for reviews, see
Holderfield and Hughes 2008; Gaengel et al.
2009; Kutcher and Herman 2009). Pericyte–
endothelial interactions are an area of active
study, and although the effects of these interac-
tions have not been directly linked to intrinsic
endothelial cell polarity, coculture shows that
basolateral basement membrane deposition
does not occur when pericytes are absent (Davis
2010). This basement membrane interacts with
the basolateral endothelial surface once depos-
ited, and integrin interactions are likely impor-
tant, although endothelial loss of b1 integrin
did not prevent pericyte–endothelial interac-
tions (Zovein et al. 2010). Several signals,
including VEGF-A and the Tie ligand Ang-1
(Darland et al. 2003), are secreted from peri-
cytes and thus are predicted to be polarized
basolaterally. Another pericyte–endothelial mo-
lecular interaction uses N-cadherin, and N-cad-
herin becomes localized to the basolateral
surface between pericytes and endothelial cells
(Paik et al. 2004). Much work remains to eluci-
date exactly how pericyte–endothelial inter-
actions influence endothelial cell and vessel
polarity, and the role of VEGF signaling in these
processes.
Blood vessel formation has most often been
compared with the formation of other epithelial
tubes. For example, both the paradigm of tip cell
versus stalk cell (Gerhardt et al. 2003) and the
idea that cells compete with each other for the
tip cell position in developing vessels (Jakobs-
son et al. 2010) are informed by seminal studies
of the Drosophila tracheal system (Samakovlis
et al. 1996; Ghabrial et al. 2003). Several modes
of lumenization are proposed to occur during
tracheal development (Lubarsky and Krasnow
2003), and some of these are now proposed
for lumenization of developing vessels. It
should be noted, however, that there are differ-
ences in the developmental programs. For
example, the fly trachea forms from cells that
do not divide as they migrate and undergo mor-
phogenesis, whereas most vascular beds expand
via endothelial cell divisions that accompany
morphogenesis. The selection of tip versus stalk
cell in the fly trachea sets up a difference in cell
fates, yet in the developing vascular system,
this distinction appears to be a phenotype as
opposed to a fate, and tip cells can revert to stalk
cells via mechanisms that are currently not well
understood. Finally, the trachea is a conduit for
air, which is a gas that brings oxygen to tissues,
whereas vessels are conduits for blood, a liquid
that imparts shear stress as it flows through ves-
sels. Thus some of the mechanisms for vessel
patterning and VEGF function are likely to be
unique to developing vessels.
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VEGF PATTERNING AT THE LEVEL OF
TISSUE/ORGANISM
VEGF signaling is important for overall vessel
patterning during development, as tissues and
organs develop and the major body axes are
set up. Seminal studies in the frog showed that
angioblasts migrate medially from the lateral
plate mesoderm toward the midline in response
to a VEGF cue, where they assemble to form the
dorsal aorta (Cleaver and Krieg 1999). In frogs
and zebrafish, VEGF is produced by a transient
midline structure called the hypochord. In avi-
ans and mammals, the dorsal aorta first forms
as bilaterally symmetrical vessels in the trunk
region, and these vessels then fuse to form a sin-
gle tube between the forelimb and hindlimb
areas on the anterior–posterior axis (for review,
see Hogan and Bautch 2004). How the initial
vessels are formed is not entirely clear, but
angioblasts first appear in areas where the ves-
sels will form, then they assemble into a cord.
VEGF-A is produced by endoderm that lies
along the midline below the nascent vessels,
and one hypothesis is that endoderm-derived
VEGF-A provides a positive midline signal for
vessel patterning in avians and mammals. How-
ever, positive signaling is not sufficient for
proper patterning of the dorsal aorta, and
another midline structure called the notochord
appears to provide negative cues for dorsal aorta
patterning. The notochord expresses inhibitors
of BMP signaling such as chordin, and develop-
mentally regulated loss of chordin expression
from the avian notochord correlates with fusion
of the dorsal aorta (Reese et al. 2004; Garriock
et al. 2010).
VEGF-A expression is dynamic during
subsequent development, and VEGF is involved
in both long-range and short-range signaling
that influences vessel patterning. In general,
VEGF expression is up-regulated in response
to tissue hypoxia mediated through the HIF
(hypoxia inducible factor) family of transcrip-
tion factors, although the initial development
of vessels early in development is HIF inde-
pendent (for review, see Simon and Keith
2008). The neural tube straddles the midline
dorsally, and it requires vascularization by
recruitment of vessels because it does not con-
tain angioblasts or endothelial cells (for reviews,
see Mancuso et al. 2008; Bautch and James
2009). A long-range signal from the neural
tube induces the migration of angioblasts
and/or endothelial cells from lateral plate and
laterally positioned somites to form a plexus
surrounding the neural tube, called the PNVP
(peri-neural vascular plexus) (Pardanaud
et al. 1996; Ambler et al. 2001). Grafts geneti-
cally deleted for flk-1 do not migrate toward
the neural tube (Ambler et al. 2003), and
neural-tube-derived VEGF-A is required for
patterning of somite-derived vessels in cocul-
tures (Hogan et al. 2004), suggesting that
VEGF-A can act as a long-range signal for vas-
cular plexus formation in development. Once
the PNVP forms, neural-tube-derived VEGF-A
acts at a shorter range to induce ingression of
vessels sprouts into the developing neural tube
(James et al. 2009). However, the stereotypical
patterning of neural tube vessel ingression likely
also involves negative cues because the VEGF-A
expression domain is broader than the vessel
ingression points. Moreover, additional attrac-
tive signals probably cooperate with VEGF in
neural tube vessel ingression, because neural
tubes lacking Wnt 7a/b or the orphan G-
protein-coupled receptor GPR124 also have
defective vessel ingression (Stenman et al.
2008; Daneman et al. 2009; Kuhnert et al. 2010).
VEGF is involved in vessel patterning in
other tissues and organs and likely also acts in
conjunction with other signals at these sites.
For example, in the developing retina, a gradient
of VEGF-A is proposed to emanate from the
distal area and induce the proximal–distal
migration of vessels from the area of the optic
nerve outward (for reviews, see Dorrell and
Friedlander 2006; Fruttiger 2007). The vessels
also migrate on an astrocyte network that is
laid down before vessel migration; although
astrocytes produce VEGF-A, this expression is
not required for the astrocyte–endothelial cross
talk involved in vessel patterning because
astrocyte-specific deletion of VEGF-A has only
minor effects on vessel patterning but dramati-
cally affects vessel stabilization (Scott et al.
2010). Nerves and arteries also follow each other
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in developing skin, and although nerve-derived
VEGF-A is important for arterial specification
of the vessels, it does not seem to provide direct
patterning cues to the vessels in this context
(Mukouyama et al. 2002, 2005).
Finally, VEGF is important for patterning of
vessel networks that form without migrating
toward an obvious source of VEGF. An example
of this type of vessel patterning is found in the
developing murine yolk sac, where VEGF-A is
produced from the endoderm that underlies
the mesoderm and also from mesoderm that
gives rise to yolk sac vessels. Endoderm-derived
VEGF is required for yolk sac vessel develop-
ment and patterning, because mosaic loss of
endoderm VEGF-A prevents vessel formation
in the mesoderm above the mutant endoderm
(Damert et al. 2002). Yolk sac vessels have an
initial phase of sprouting angiogenesis and
expand in the lateral plane, then the network
undergoes extensive remodeling once blood
flow commences (for review, see Culver and
Dickinson 2010). It is interesting to speculate
that vessel-derived negative cues, such as
sFlt-1, may shape VEGF presentation to provide
vessel-patterning cues in the lateral plane of the
developing yolk sac.
CONCLUSIONS AND PERSPECTIVES
The last several years have provided important
information regarding specific mechanisms
whereby a single signaling pathway, instigated
by the VEGF-A ligand, can influence and pat-
tern vessels at several scales, from cell to organ-
ism. We also better understand how VEGF
signaling intersects with numerous other
important signaling pathways, such as Notch–
Delta and BMP, to modulate vessel develop-
ment. We now appreciate that the spatial
context of both the signals and the negative
modulator Flt-1 is critical for proper pattern-
ing. We are beginning to understand how
VEGF signaling influences polarity and other
group behaviors of endothelial cells. Finally,
we realize that VEGF is a critical component
of the cross talk that is necessary between devel-
oping organs and tissues in an embryo and the
vessels that provide nourishment, and we
anticipate that intersection with other pathways
is also important for this role of VEGF.
There is still much to be learned. We under-
stand that localization of VEGF pathway com-
ponents spatially is important, but we have
not yet developed the ability to interrogate sig-
naling in vivo using in situ probes. The evidence
for VEGF gradients is indirect, and we are lack-
ing essential knowledge of how VEGF gradients
are set up, maintained, and interpreted. There is
a strong interest in modeling aspects of VEGF
signaling and interactions with other pathways
using computational approaches (Bentley et al.
2008; Mac Gabhann and Popel 2008; Peirce
2008), and going forward a stronger integration
of mathematical models and experimental read-
outs will result in a more complete understand-
ing of VEGF signaling. VEGF receptors that
bind ligands other than VEGF-A, such as
VEGFR3/flt-4, are clearly important in vessel
patterning (Lohela et al. 2009), but their role
is much less understood. Finally, VEGF-A is
important for arterial identity in some develop-
mental contexts, and not all of the regulation of
this aspect of VEGF signaling is well under-
stood. As our knowledge of how VEGF patterns
vessels is refined, it will be exciting to see how
this knowledge contributes to development and
refinement of the therapies sought by Judah
Folkman and the field of vascular biology.
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gram. With hindsight, Dr. Folkman’s philoso-
phy that the field needed scientists with new
tools and new approaches and his incredible
energy to both recruit and support young scien-
tists were both unique and forward-looking.
His legacy and our mandate is to continue to
seek out and support new investigators, with
new approaches and ideas, to keep the field of
vascular biology as exciting and innovative as
it is today. I thank all past and current members
of the Bautch laboratory, and numerous
colleagues, for stimulating discussions. I also
thank Dr. Sarah Taylor for the retinal vessel
micrograph. I apologize to colleagues whose
work was not cited as primary literature because
of space constraints. This work is supported by
grants from the National Institutes of Health
(NIH) (R01s HL43174 and HL86465) to V.L.B.
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